[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:urinary-tract-squamous-cell-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Urinary Tract Squamous Cell Carcinoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06161532","Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder\u002FUrinary Tract Cancer, Renal Medullary Carcinoma and Penile C...",[11],"Phase 2","RECRUITING","2026-08-26T02:16:46.147215Z","2026-05-05T02:43:28.172497Z",[],[]]